Developer docs
API playgroundTry for free, no card

Search company profiles

Benchmark Research

Full company profile

uuid000e8oa

Namestring
Benchmark Research
Legal namestring
Benchmark Research
Company typeenum
Private
Founded yearint
1997
Descriptiontext

Benchmark Research is a clinical research organization headquartered in Austin, Texas, founded in 1997 and operating with 101-250 employees. The company specializes in vaccine research and rapid patient enrollment services for clinical trials, positioning itself on speed-to-enrollment within the pharmaceutical research services market. Following a 2025 acquisition by QCare Site Services, Inc., Benchmark Research was integrated into the Avacare Clinical Research Network and no longer operates as a standalone entity; the website and customer materials now route to avacare.com.

The core product offering, as reconstituted through Avacare, is a centralized clinical research network that connects four stakeholder groups: sponsors and contract research organizations (CROs), clinical research sites, and patients. Sponsor/CRO-facing capabilities emphasize centralized network access, research-experienced investigators, and data-driven operations intended to accelerate trial timelines while preserving quality. Site-facing capabilities provide tooling, operational support, and access to trial opportunities to reduce administrative burden on investigator sites. Patient-facing capabilities are delivered through a dedicated trial-finder platform (avacareclinicaltrials.com) that surfaces open studies near participants.

The business model is a clinical research site services model under a multi-sided platform wrapper. Specific pricing, contract structures, fee-per-enrolled-patient economics, or revenue mechanics are not disclosed in the available source material. The firm is privately held, with Mark Lacy identified as Owner, Founder, President, and CEO prior to or at the time of integration. The site's product and customer segmentation logic suggests sponsor/CRO contracting as the primary revenue channel, with sites and patients as upstream and downstream participants in the network rather than direct paying customers.

Short descriptiontext

Benchmark Research, founded in 1997 in Austin, Texas, provides vaccine research and rapid patient enrollment services for clinical trials. Since 2025 it has operated as a site within the Avacare Clinical Research Network, connecting sponsors, CROs, sites, and patients.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical research services, vaccine research, clinical trial network, patient enrollment, site management
Industry3 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
NAICS code1 code
  • Medical Laboratories621511
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services
Social media profiles2 records
Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Benchmark Research provides vaccine and clinical research services with rapid patient enrollment capabilities. Operating as part of the Avacare Clinical Research Network, the company delivers centralized clinical trial execution by connecting sponsors, CROs, research sites, and patients through research-experienced investigators and data-driven operations.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Benchmark Research operates as part of Avacare Clinical Research Network, a unified platform offering interconnected services for clinical trial stakeholders. The network provides centralized infrastructure connecting sponsors and CROs with research-experienced investigators, offering data-driven operations support for trial acceleration without compromising quality. Additional services support clinical research sites with tools and trial opportunities, while a dedicated patient platform enables participation in clinical trials near them.

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Benchmark Research has become part of Avacare Clinical Research Network, merging to share a common goal of driving healthcare forward to improve patient lives. The combined entity creates meaningful connections between people seeking new treatments and those providing them, with focus on safety, convenience, quality, and speed in clinical trial operations.

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Flourish is a multi-site clinical research organization operating dedicated research sites with a therapeutic mix including vaccines, internal medicine, and specialty indications. Like Benchmark, Flourish supports sponsors and CROs with site-based trial execution and rapid-enrollment capabilities.

TypeBroad incumbent
Description

ICON operates a global clinical research site network (including via its PRA Health Sciences acquisition) serving sponsors across all major therapeutic areas. Comparable to Benchmark as a competing site-network option for sponsors running vaccine and Phase I–IV trials.

TypeBroad incumbent
Description

Syneos operates a clinical research site network and full-service CRO offering overlapping capabilities in vaccine and therapeutic trial execution. Comparable to Benchmark as a sponsor-facing alternative for site-based clinical research services.

TypeDirect peer
Description

Elligo runs a decentralized network combining traditional sites with technology-enabled trial access for sponsors, with comparable focus on accelerating enrollment. Both Elligo and Benchmark compete for sponsors seeking site-network partnerships that prioritize enrollment speed and quality.

TypeDirect peer
Description

Velocity operates an integrated network of clinical trial sites across the U.S. with a comparable focus on multi-therapeutic trial execution and rapid enrollment. Like Benchmark, Velocity provides centralized infrastructure for sponsors and CROs and competes for similar vaccine and infectious disease trial placements.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO and a direct connection to Benchmark's new parent — Avacare Clinical Research Network is operated by QCare Site Services, Inc., whose website links directly to IQVIA's careers, privacy, and corporate pages. IQVIA's site-management arm is the closest broad incumbent to Benchmark's site-based clinical trial operations.

TypeBroad incumbent
Description

Worldwide is a mid-sized CRO with site-management services spanning vaccines, oncology, and rare disease — directly comparable to Benchmark's therapeutic focus and mid-tier operational scale.

TypeEmerging player
Description

WCG provides central IRB services, site enablement technology, and trial optimization tools used by site networks including organizations like Benchmark. Comparable as an enabling partner that supports the operational infrastructure of clinical research sites rather than directly competing for trial placements.

TypeOthers
Description

Clincierge and similar patient-retention/logistics vendors support site networks and CROs with travel and concierge services for trial participants — comparable to Benchmark as part of the broader site-network operational ecosystem that sponsors and CROs coordinate with.

TypeBroad incumbent
Description

Medpace is a mid-to-large CRO with significant site-management operations and therapeutic specialization across multiple areas including vaccines and infectious disease. Comparable to Benchmark at the sponsor-CRO interface and competes for similar trial placement opportunities via its site network.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Benchmark Research

Clinical Research Servicesbenchmarkresearch.net

Benchmark Research, founded in 1997 in Austin, Texas, provides vaccine research and rapid patient enrollment services for clinical trials. Since 2025 it has operated as a site within the Avacare Clinical Research Network, connecting sponsors, CROs, sites, and patients.

What Benchmark Research does

Benchmark Research is a clinical research organization headquartered in Austin, Texas, founded in 1997 and operating with 101-250 employees. The company specializes in vaccine research and rapid patient enrollment services for clinical trials, positioning itself on speed-to-enrollment within the pharmaceutical research services market. Following a 2025 acquisition by QCare Site Services, Inc., Benchmark Research was integrated into the Avacare Clinical Research Network and no longer operates as a standalone entity; the website and customer materials now route to avacare.com.

The core product offering, as reconstituted through Avacare, is a centralized clinical research network that connects four stakeholder groups: sponsors and contract research organizations (CROs), clinical research sites, and patients. Sponsor/CRO-facing capabilities emphasize centralized network access, research-experienced investigators, and data-driven operations intended to accelerate trial timelines while preserving quality. Site-facing capabilities provide tooling, operational support, and access to trial opportunities to reduce administrative burden on investigator sites. Patient-facing capabilities are delivered through a dedicated trial-finder platform (avacareclinicaltrials.com) that surfaces open studies near participants.

The business model is a clinical research site services model under a multi-sided platform wrapper. Specific pricing, contract structures, fee-per-enrolled-patient economics, or revenue mechanics are not disclosed in the available source material. The firm is privately held, with Mark Lacy identified as Owner, Founder, President, and CEO prior to or at the time of integration. The site's product and customer segmentation logic suggests sponsor/CRO contracting as the primary revenue channel, with sites and patients as upstream and downstream participants in the network rather than direct paying customers.

Benchmark Research firmographics

Firmographics
Name
Benchmark Research
Legal name
Benchmark Research
Website
https://benchmarkresearch.net
Company type
Private
Founded year
1997
Operating status
Acquired
Headcount range
101–250 employees
Short description
Benchmark Research, founded in 1997 in Austin, Texas, provides vaccine research and rapid patient enrollment services for clinical trials. Since 2025 it has operated as a site within the Avacare Clinical Research Network, connecting sponsors, CROs, sites, and patients.
Ownership category
akta.pro rank

Benchmark Research industry classification

Industry
Product category
Clinical Research Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Keywords

  • Clinical research services
  • Vaccine research
  • Clinical trial network
  • Patient enrollment
  • Site management

Where Benchmark Research is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Markets served

Benchmark Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Benchmark Research product offering

Product offering

Core offering

Benchmark Research provides vaccine and clinical research services with rapid patient enrollment capabilities. Operating as part of the Avacare Clinical Research Network, the company delivers centralized clinical trial execution by connecting sponsors, CROs, research sites, and patients through research-experienced investigators and data-driven operations.

Product overview

Benchmark Research operates as part of Avacare Clinical Research Network, a unified platform offering interconnected services for clinical trial stakeholders. The network provides centralized infrastructure connecting sponsors and CROs with research-experienced investigators, offering data-driven operations support for trial acceleration without compromising quality. Additional services support clinical research sites with tools and trial opportunities, while a dedicated patient platform enables participation in clinical trials near them.

Differentiator

Problem solved

Functional benefit

Companies that use Benchmark Research

Customer profile

Segments3 records

Ideal customer profiles3 records

Benchmark Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Benchmark Research partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Avacare Clinical Research NetworkcoreStrategic or Co-development PartnerBenchmark Research has become part of Avacare Clinical Research Network, merging to share a common goal of driving healthcare forward to improve patient lives. The combined entity creates meaningful connections between people seeking new treatments and those providing them, with focus on safety, convenience, quality, and speed in clinical trial operations.

Recent moves2 records

Expansion highlights3 records

Benchmark Research competitors and assessment

Company assessment

Direct peers

  • Flourish Research: Flourish is a multi-site clinical research organization operating dedicated research sites with a therapeutic mix including vaccines, internal medicine, and specialty indications. Like Benchmark, Flourish supports sponsors and CROs with site-based trial execution and rapid-enrollment capabilities.
  • Elligo Health Research: Elligo runs a decentralized network combining traditional sites with technology-enabled trial access for sponsors, with comparable focus on accelerating enrollment. Both Elligo and Benchmark compete for sponsors seeking site-network partnerships that prioritize enrollment speed and quality.
  • Velocity Clinical Research: Velocity operates an integrated network of clinical trial sites across the U.S. with a comparable focus on multi-therapeutic trial execution and rapid enrollment. Like Benchmark, Velocity provides centralized infrastructure for sponsors and CROs and competes for similar vaccine and infectious disease trial placements.

Broad incumbents

  • ICON plc: ICON operates a global clinical research site network (including via its PRA Health Sciences acquisition) serving sponsors across all major therapeutic areas. Comparable to Benchmark as a competing site-network option for sponsors running vaccine and Phase I–IV trials.
  • Syneos Health: Syneos operates a clinical research site network and full-service CRO offering overlapping capabilities in vaccine and therapeutic trial execution. Comparable to Benchmark as a sponsor-facing alternative for site-based clinical research services.
  • IQVIA: IQVIA is the world's largest CRO and a direct connection to Benchmark's new parent — Avacare Clinical Research Network is operated by QCare Site Services, Inc., whose website links directly to IQVIA's careers, privacy, and corporate pages. IQVIA's site-management arm is the closest broad incumbent to Benchmark's site-based clinical trial operations.
  • Worldwide Clinical Trials: Worldwide is a mid-sized CRO with site-management services spanning vaccines, oncology, and rare disease — directly comparable to Benchmark's therapeutic focus and mid-tier operational scale.
  • Medpace: Medpace is a mid-to-large CRO with significant site-management operations and therapeutic specialization across multiple areas including vaccines and infectious disease. Comparable to Benchmark at the sponsor-CRO interface and competes for similar trial placement opportunities via its site network.

Emerging players

  • WCG (WIRB-Copernicus Group): WCG provides central IRB services, site enablement technology, and trial optimization tools used by site networks including organizations like Benchmark. Comparable as an enabling partner that supports the operational infrastructure of clinical research sites rather than directly competing for trial placements.

Others

  • Clincierge: Clincierge and similar patient-retention/logistics vendors support site networks and CROs with travel and concierge services for trial participants — comparable to Benchmark as part of the broader site-network operational ecosystem that sponsors and CROs coordinate with.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Benchmark Research social profiles

Digital presence

Benchmark Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Benchmark Research leadership team

Management profile

Number of profiles

Profiles1 record

Benchmark Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Benchmark Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Benchmark Research

What does Benchmark Research do?

Benchmark Research provides vaccine and clinical research services with rapid patient enrollment capabilities. Operating as part of the Avacare Clinical Research Network, the company delivers centralized clinical trial execution by connecting sponsors, CROs, research sites, and patients through research-experienced investigators and data-driven operations.

When was Benchmark Research founded?

Benchmark Research was founded in 1997. It employs 101 to 250 people.

Where is Benchmark Research based?

Benchmark Research is headquartered in Austin, United States, in the North America region.

Who are Benchmark Research's main competitors?

Direct peers on record are Flourish Research, Elligo Health Research and Velocity Clinical Research. Broad incumbents are ICON plc, Syneos Health, IQVIA, Worldwide Clinical Trials and Medpace. WCG (WIRB-Copernicus Group) is listed as an emerging player. Clincierge is listed as an others.

Does Benchmark Research have an API?

No public API is recorded for Benchmark Research.

What industry is Benchmark Research in?

Benchmark Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals